谁在买卖 AVLN (Q2 2026)
持有机构数 (Q2 2026)94
新进持仓94
加仓0
减仓0
清仓退出0
截至Q2 2026,共 94 家机构申报持有 AVLN(AVALYN PHARMACEUTICALS INC):94 家新建仓,0 家加仓,0 家减仓,0 家清仓退出。13F 申报为季末快照,反映的是机构在季度末的持仓调整方向,并非季度内的实时交易。
新进持仓 (20 of 94)
| 基金 | 股数 | 金额 | 权重 |
|---|---|---|---|
| Fidelity Management & Research (FMR) 新进 | 5.84M | $192.10M | 0.0 |
| Novo Holdings A/S 新进 | 3.88M | $127.84M | 7.4 |
| SR ONE CAPITAL MANAGEMENT, LP 新进 | 3.31M | $108.92M | 10.5 |
| PERCEPTIVE ADVISORS LLC 新进 | 2.68M | $88.07M | 1.4 |
| MONTANOVA CAPITAL, LLC 新进 | 2.50M | $82.40M | 1.5 |
| NVP Associates, LLC 新进 | 2.27M | $74.68M | 22.8 |
| WELLINGTON MANAGEMENT GROUP LLP 新进 | 2.20M | $72.49M | 0.0 |
| PRICE T ROWE ASSOCIATES INC /MD/ 新进 | 1.74M | $57.12M | 0.0 |
| Catalio Capital Management, LP 新进 | 1.68M | $55.17M | 10.4 |
| T. Rowe Price Investment Management, Inc. 新进 | 1.60M | $52.76M | 0.0 |
| EVENTIDE ASSET MANAGEMENT, LLC 新进 | 1.38M | $45.28M | 0.6 |
| Bellevue Group AG 新进 | 1.35M | $44.44M | 0.9 |
| BlackRock Inc 新进 | 977.26K | $32.17M | 0.0 |
| Pivotal bioVenture Partners Investment Advisor LLC 新进 | 966.79K | $31.83M | 10.3 |
| Citadel Advisors 新进 | 959.10K | $31.57M | 0.0 |
| Andera Partners 新进 | 929.82K | $30.61M | 14.8 |
| JENNISON ASSOCIATES LLC 新进 | 812.75K | $26.76M | 0.0 |
| BRAIDWELL LP 新进 | 801.39K | $26.38M | 1.0 |
| TPG GP A, LLC 新进 | 773.07K | $25.45M | 0.5 |
| VANGUARD CAPITAL MANAGEMENT LLC 新进 | 739.77K | $24.35M | 0.0 |
加仓 (0)
本季度无加仓。
减仓 (0)
本季度无减仓。
清仓退出 (0)
本季度无清仓。